Skip to main content
. 2021 May 17;11:603271. doi: 10.3389/fonc.2021.603271

Figure 3.

Figure 3

The development time for BM ranged from 7.0 to 26.3 months from the date of diagnosis. The actuarial risk of developing BM at 1 year was 14.3% in patients with high-level lncRNA XR_429159.1 vs. 31.0% in the low-level group. p = 0.035.